A CGG-repeat expansion in the premutation range in the Fragile X mental retardation 1 gene (FMR1) has been identified as the genetic cause of Fragile X-associated tremor/ataxia syndrome (FXTAS), a late-onset neurodegenerative disorder that manifests with action tremor, gait ataxia and cognitive impairments. In this study, we used a bigenic mouse model, in which expression of a 90CGG premutation tract is activated in neural cells upon doxycycline administration-P90CGG mouse model. We, here, demonstrate the behavioural manifestation of clinically relevant features of FXTAS patients and premutation carrier individuals in this inducible mouse model. P90CGG mice display heightened anxiety, deficits in motor coordination and impaired gait and represent the first FXTAS model that exhibits an ataxia phenotype as observed in patients. The behavioural phenotype is accompanied by the formation of ubiquitin/FMRpolyglycine-positive intranuclear inclusions, as another hallmark of FXTAS, in the cerebellum, hippocampus and amygdala. Strikingly, upon cessation of transgene induction the anxiety phenotype of mice recovers along with a reduction of intranuclear inclusions in dentate gyrus and amygdala. In contrast, motor function deteriorates further and no reduction in intranuclear inclusions can be observed in the cerebellum. Our data thus demonstrate that expression of a 90CGG premutation expansion outside of the FMR1 context is sufficient to evoke an FXTAS-like behavioural phenotype. Brain region-specific neuropathology and (partial) behavioural reversibility make the inducible P90CGG a valuable mouse model for testing pathogenic mechanisms and therapeutic intervention methods.
Introduction
The Fragile X mental retardation 1 (FMR1) gene has an unstable CGG repeat in its 5 0 untranslated region, with a normal range of 5-44 trinucleotide repeats, that can expand into a premutation (55-200 CGG repeats) or into a full mutation (> 200 CGG repeats) (1) . While the latter causes Fragile X syndrome, the premutation in the FMR1 CGG repeat was identified as the genetic cause for Fragile X-associated tremor/ataxia syndrome (FXTAS, #300623), a late onset neurodegenerative disorder that affects around 40% of carrier men in their fifty's, and to a much lower extent women (11-18%) (2) (3) (4) . The premutation carrier frequency varies across populations and recent estimates found that 1:151/157 females and 1:468/251 males carry the premutation (5, 6) . The prevalence of FXTAS is estimated to affect 1:3000 males in the general population (3) . In women the FMR1 premutation can also cause Fragile X-associated primary ovarian insufficiency (FXPOI) (7) . The clinical spectrum of the FMR1 premutation is broad, and carriers can be affected by a variety of medical and psychological problems ranging from neurodevelopmental disorders (autism spectrum disorder and attention deficit hyperactivity disorder (ADHD)), to psychiatric disorders (anxiety and mood) and cognitive impairments (reviewed in (8) ). Whether these are early manifestations of FXTAS or independent clinical entities is still not clear and further research, particularly longitudinal studies, are needed. The pathological hallmark of FXTAS is the formation of intranuclear inclusions in neurons and astrocytes throughout the brain (9) . These appear to result from increased expression of premutated CGG Fmr1 RNA, which however is accompanied by normal to slightly reduced levels of the encoded Fragile X mental retardation protein (FMRP) (10) . Both Fmr1 RNA and non-AUG initiated (RAN) translation products have been found in the ubiquitin-positive intranuclear inclusions, implicating RNA gain-of-function and repeat-associated RAN translation as putative mechanisms of disease (11) (12) (13) . Several proteins that bind preferentially to expansions of the CGG repeat in the premutation range are sequestered in the intranuclear inclusions and thought to contribute to the disease process (14) (15) (16) (17) (18) (19) . These proteins are implicated in different biological mechanisms that can underlie the wide clinical spectrum associated with the FMR1 premutation.
Mouse models of the Fmr1 premutation have previously been generated using gene targeting technology (20) (21) (22) . These have proven helpful for analysing the molecular and pathology mechanisms of FXTAS, but the critical motor component of the disorder remained rather mildly affected in these mice (reviewed in (23) ). Thus, recapitulation of gait ataxia has not been reported in a FXTAS animal model so far. Moreover, mechanisms underlying altered emotional behaviour in FXTAS are still relatively unexplored. Recently, with the development of a transgenic mouse with inducible expression of a 90CGG repeat mRNA (outside the context of Fmr1 gene), it has become possible to isolate the CGG-rich mRNA as the pathogenic principle and, moreover, to test for critical time windows of premutation expression in FXTAS pathology as well as in its reversibility (24, 25) . In this mouse model expression of the 90CGG tract in the brain was found to be sufficient for triggering the formation of intranuclear inclusions containing both ubiquitin and FMRpolyglycine (FMRpolyG) in the cerebellum, striatum and hippocampus (25) . Additionally, it is possible to allow for spontaneous dissolving of the formed intranuclear inclusions merely by stopping transgene induction, during the early stages of transgene induction (up to c. 8 weeks).
In this study we focused on two FXTAS clinical hallmarksmotor impairments and emotional disturbance-and investigated their reversibility and their relation to intranuclear inclusion formation in this FXTAS mouse model. Taking advantage of the inducible nature of this model, we manipulated the duration of transgene expression and thus could relate the induction time threshold required for the development of motor impairments and heightened anxiety with the inclusion load in corresponding brain regions. Further, we examined the potential for spontaneous recovery of behavioural functions and associated removal of inclusions upon cessation of transgene expression in different stages of pathology development. Our data suggest that intervention with CGG tract expression during early stages of pathology development bears the potential for a recovery of behavioural functions in FXTAS.
Results
Activation of 90CGG premutation in the brain of juvenile mice models hallmark neurological features of FXTAS The rotarod test is commonly used to assess motor coordination and motor learning and has previously shown subtle deficits in another FXTAS mouse model (26) . P90CGG animals that received DOX for a 12-week period (P90CGG DOXþ, n ¼ 17 and P90CGG DOX-control animals, n ¼ 11) were first trained for three consecutive days at 15 rpm constant speed and then tested on the fourth day for motor learning (at different constant speeds) as well as motor coordination (5 min, 4-40 rpm acceleration ramp). In training sessions, P90CGG DOXþ animals showed a lower latency to fall off the rod than P90CGG DOX-controls ( Fig. 1A ; genotype effect, F 1, 26 ¼ 4.354, P ¼ 0.047). This difference is due to poor performance on the first day of training and is overcome upon further training (day 2 and day 3), when no difference is observed in P90CGG DOXþ performance as compared with controls. Motor learning was evaluated by testing the animals at constant speed using five different speed values. At 36 rpm, P90CGG DOXþ animals showed a lower latency to fall of the rod than controls ( Fig. 1B ; t ¼ 2.802, P ¼ 0.0095). No differences between groups were found for any of the other tested speeds (Fig. 1B) . Motor coordination was evaluated by forcing the animals to run in an accelerated rotating rod from 4 to 40 rpm in a 5 min period. Again, P90CGG DOXþ fell off the rod earlier than P90CGG DOX-control animals ( Fig. 1C ; t ¼ 2.690, P ¼ 0.012).
Cerebellar gait ataxia is a cornerstone motor impairment in premutation carriers affected with FXTAS (2) . In mouse models of neurodegenerative disorders, such as Huntington and Machado-Joseph's, footprint patterns are used successfully to directly assess cerebellar ataxia (27, 28) . We obtained footprints from all mice (P90CGG DOXþ n ¼ 17, P90CGG DOX-n ¼ 11) and analysed different parameters: fore-and hindpaws width, stride length and uniformity of step alternation (Fig. 1D) . We found that P90CGG DOXþ animals have an increased width in the uniformity of step alternation measure ( Fig. 1J ; t ¼ 2.944, P ¼ 0.0067). No statistically significant differences were found in the other parameters analysed (Fig. 1G-I ). We also registered body weight of animals, as this can affect motor performance, but did not observe differences between groups (body weight (g), P90CGG DOX-¼ 32.02 6 0.57; P90CGG DOXþ ¼ 32.63 6 0.53).
In summary, motor impairments are present in P90CGG DOXþ animals activated with DOX for a period of 12 weeks. These motor impairments mimic well the ataxia symptoms exhibited by FXTAS patients and are here for the first time mimicked in a mouse model of this disorder.
Activation of 90CGG premutation in the brain of juvenile mice models other premutation-related phenotypes of carriers and FXTAS To examine spontaneous locomotor activity and anxiety, mice (P90CGG DOXþ n ¼ 17, P90CGG DOX-n ¼ 11) were first tested in the open field apparatus in a 20 min session. P90CGG DOXþ animals travelled the same distance and showed a similar habituation to the arena, as compared with P90CGG DOX-animals ( Fig. 2A ; genotype effect, F 1, 26 ¼ 1.745, P ¼ 0.198; time effect F 3, 78 ¼ 132.0, P < 0.0001). Interestingly, P90CGG DOXþ animals spent significantly less time in the centre in relation to the remaining area of the arena than their P90CGG DOX-controls ( Fig. 2B ; genotype effect, F 1, 26 ¼ 7.175, P ¼ 0.013), reflecting a heightened anxiety phenotype. Of note, anxiety disorders are prominent in premutation carriers (29) .
To further explore the locomotor profile, home-cage activity of single caged P90CGG DOXþ/-animals (P90CGG DOXþ n ¼ 14, P90CGG DOX-n ¼ 8) was registered for three consecutive days (Fig. 2C ). Both P90CGG DOXþ and P90CGG DOX-animals show a similar circadian pattern with increased activity during the lights OFF period and reduced activity during the lights ON period. However, overall P90CGG DOXþ animals have increased levels of activity as compared with controls (genotype Â time interaction, F 23, 460 ¼ 1.703, P ¼ 0.023). Interestingly, the hyperactivity exhibited by P90CGG DOXþ animals occurs in the lights OFF period (Fig. 2D , t ¼ 2.909, P ¼ 0.0058), but not in the lights ON period (t ¼ 0.668, P ¼ 0.508).
To test for possible emotional learning and memory impairments mice were tested in the auditory fear-conditioning paradigm (P90CGG DOXþ n ¼ 15, P90CGG DOX-n ¼ 14). No differences were observed in the percentage of basal freezing levels between P90CGG DOXþ and respective P90CGG DOX-controls, when animals were first presented to the conditioning box in the habituation session (data not shown, P ¼ 0.509). Moreover, in the habituation session P90CGG DOXþ and control animals presented similar values of freezing levels in response to the presentation of unpaired conditioned stimulus (CS-, Fig. 2E , genotype effect, F 1, 27 ¼ 0.254, P ¼ 0.618), showing that per se P90CGG DOXþ and P90CGG DOX-animals respond equally to neutral auditory stimuli (CS-effect, F 2, 54 ¼ 0.781, P ¼ 0.463). In the training session, the paired conditioned stimulus (CSþ) was presented together with a mild footshock (US) to generate a conditioned freezing response. Here, both P90CGG DOXþ and P90CGG DOX-animals showed an increase in the percentage of freezing levels with consecutive CS þ presentations (Fig. 2F , CSþ effect, F 2, 54 ¼ 11.685, P < 0.0001), with no differences between groups (genotype effect, F 1, 27 ¼ 0.167, P ¼ 0.686). Contextual fear memory was tested 24 h after the training session by placing the animals back in the training box without the presentation of either CS þ or the US. No differences were observed in the percentage of freezing levels between P90CGG DOXþ and P90CGG DOX-groups (Fig. 2G , t ¼ 0.0699, P ¼ 0.909). Cued-fear memory was tested 48 h after the training session, by placing the animals in a new Figure 1 . Motor Impairments in the inducible P90CGG DOXþ animals mimic FXTAS ataxic gait. Inducible P90CGG animals were given a 12-week period of doxycycline administration, starting after weaning, and tested in a behavioural battery that includes evaluation of motor function in the rotarod and footprint pattern. (A) In the training sessions, P90CGG DOXþ animals showed a worse performance than P90CGG DOX-controls, which was overcome with overtraining and P90CGG DOXþ animals were able to reach the same performance levels as controls (repeated measures two-way ANOVA, P90CGG DOX-n ¼ 11, P90CGG DOXþ n ¼ 17). In the fourth day, the same animals were tested for (B) motor learning and (C) motor coordination and for both paradigms P90CGG DOXþ animals showed deficits in performance as compared with controls (Student's t-test). (D) Footprints were obtained for all animals (P90CGGDOX-n ¼ 11, P90CGGDOXþ n ¼ 17) and used to analyse the gait pattern by measuring (d1) frontpaws width, (d2) hindpaws width, (d3) stride length and (d4) uniformity of step alternation. Representative footprint patterns of P90CGG animals treated (E) without and (F) with DOX. P90CGG DOXþ animals showed an increase in the width of uniformity of step alternation as compared with P90CGG DOX-control animals (J) and no differences in the other parameters analysed (G-I) (Student's t-test). P90CGG.DOX-, animals administered 5% saccharose; P90CGG.DOXþ, animals administered doxycycline.
Repeated measures two-way ANOVA, genotype effect, # P < 0.05; Student's t-test, *P < 0.05, **P < 0.01. 
Lack of behavioural impairments in P11CGG DOXþ animals
An independent transgenic mouse line (11CGG) has previously been generated to control for the expected relevance of CGG tract length in FXTAS pathology development (25) . In fact, although RNA expression levels of 11CGG and 90CGG transgenes are comparable in both lines, only the latter form the typical nuclear inclusions (25) . We therefore further tested P11CGG DOXþ (n ¼ 12) that were given a 12-week DOX period and their P11CGG DOX-(n ¼ 11) controls in the behavioural tasks for which we observed significant differences between P90CGG DOXþ and P90CGG DOX-animals. When tested in the rotarod for motor learning, P11CGG DOXþ animals showed a lower latency to fall off the rod than P11CGG DOX-controls at 36 rpm (Fig. 3B , t ¼ 4.067, P < 0.001), similar to what was observed in P90CGG animals ( Fig. 1b) . However, no other differences were observed between P11CGG DOXþ and their respective controls in the rotarod for motor training or motor coordination ( (Fig. 4F, 
Overall, the data suggest that the initial 90CGG transgene induction had permanent consequences for motor function that could not be rescued by mere cessation of transgene expression.
On the other hand, we did observe a spontaneous recovery of anxiety-related behaviour after transgene silencing.
Inclusion formation in cerebellum, hippocampus and amygdala regions before and after termination of 90CGG transgene expression
As a hallmark of FXTAS pathology and putative neurotoxic principle, we studied the formation of intranuclear inclusions (ubiquitin-positive and FMRpolyG-positive) in brain regions that are critically involved in the studied behaviours. Thus, after completion of the behavioural characterization, we quantified the number of ubiquitin-positive intranuclear inclusions in the cerebellum lobule X, amygdala-central (CeA) and basolateral nuclei (BLA)-and hippocampal sub-regions (dentate gyrus (DG) and cornu ammonis CA3 and CA1) of P90CGG animals after DOX induction (P90CGG DOXþ n ¼ 7/9) and after DOX washout (P90CGG DOXþ.WO n ¼ 7/10). The percentage of nuclei with ubiquitin-positive intranuclear inclusions was 41.2% in the cerebellum lobule X, 14.9% in CeA and 17.8% in the BLA and 16.4% in the CA3 sub-region of the hippocampus (Fig. 5A-G) . Residual intranuclear inclusions in the DG and CA1 sub-regions of the hippocampus were low, i.e. <5% (Fig. 5A-G) . Following an additional 12-week washout period, the percentage of ubiquitin-positive intranuclear inclusions in the abovedescribed regions was quantified and compared with the prewashout values (Fig. 5G ). In the cerebellum lobule X we observed that 35.6% of nuclei have ubiquitin-positive inclusions, showing that a 12-week washout period did not result in a washout of the existing inclusions (35.6 versus 41.2% in prewashout time point, t ¼ 0.821, P ¼ 0.423), which is in accordance with data published previously (25) . Importantly however, the 12-week washout period resulted in a significantly lower percentage of ubiquitin-positive nuclei in the BLA (7.1 versus 17.8%, t ¼ 3.22, P ¼ 0.0061) and DG (1.1 versus 5.4%, t ¼ 2.52, P ¼ 0.023), and almost significant reduction in CeA (8.3 versus 14.9%, t ¼ 1.94, P ¼ 0.075) and CA3 (8 versus 16.4%, t ¼ 1.98, P ¼ 0.066) (Fig. 5G) . These neuropathology data parallel our behavioural findings in that P90CGG DOXþ animals after a washout period exhibit a rescue in anxiety levels together with a washout of intranuclear inclusions in the amygdala and hippocampus, whereas persistent motor impairments are observed together with high number of intranuclear inclusions in cerebellum lobule X.
Activation of 90CGG transgene for an 8-week period in the brain of juvenile mice is not sufficient for motor rescue
Since the higher initial inclusion load and their incomplete dissolving in the cerebellum might explain the inability of mice to recover motor functions after washout, we next examined these functions in an earlier stage of pathology development. It has been reported previously that inclusions formed in the cerebellum lobule X during a period of 8 weeks DOX administration are smaller in size and number (25) . Indeed, the behavioural phenotype of mice in our experiments was rather mild after a short, 8-week period of DOX administration (P90CGG DOXsþ n ¼ 15, P90CGG DOXs-n ¼ 14). On the rotarod, no differences were observed between genotypes in the training sessions (Fig. 6A) , motor learning at any of the constant speeds tested (Fig. 6B ) or in motor coordination (Fig. 6C) . When we analysed footprint patterns for several gait parameters in this group no differences were observed between P90CGG DOXsþ and P90CGG DOXs-animals Figure 3 . No motor impairments or anxiety alterations were observed in the inducible P11CGG mouse model. Inducible P11CGG animals were given a 12-week period of doxycycline administration, starting after weaning, and then tested in the behavioural paradigms for which P90CGG DOXþ animals showed differences as compared with their P90CGG DOX-controls. The objective is to distinguish whether P90CGG DOXþ behavioural alterations are indeed due to CGG repeat size or whether RNA load could account for the observed differences. (A) In the training sessions of the rotarod paradigm P11CGG DOXþ acquire the task as well as P11CGG DOX-animals (repeated measures two-way ANOVA, P11CGGDOX-n ¼ 11, P11CGGDOXþ n ¼ 12). (B) When testing motor learning, at 36 rpm P11CGGDOXþ animals showed a reduction in the latency to fall off the rod, as compared with P11CGG DOX-animals (Student's t-test). (C) No differences in motor coordination were observed between P11CGG treatment groups (Student's t-test). Analysis of footprint patterns showed no differences in gait between P11CGG DOXþ and P11CGG DOX-animals when (D) forepaws width, (E) hindpaws width, (F) stride length and (G) uniformity of step alternation parameters were measured (Student's t-test, P11CGG DOX-n ¼ 11, P11CGG DOXþ n ¼ 12). No differences were observed in the performance of P11CGGdoxþ and P11CGGDOX-animals in the (H) total distance travelled and (I) percentage of time spent in the centre of the arena of the open field (repeated measures two-way ANOVA, P11CGG DOX-n ¼ 11, P11CGG DOXþ n ¼ 12). (J, K) Assessment of home cage activity in a 24-h period for three consecutive days showed no differences in spontaneous locomotor activity between P11CGG DOXþ/DOX-treatment groups (repeated measures two-way ANOVA, P11CGG DOX-n ¼ 11, P11CGG DOXþ n ¼ 12). P11CGG.DOX-, animals administered 5% saccharose; P11CGG.DOXþ, animals administered doxycycline. Repeated measures two-way ANOVA, training/time effect, § § P < 0.01, § § § P < 0.001; time Â genotype effect, &&& P < 0.001; Student's t-test, ***P < 0.001. P90CGG.DOX-, animals administered 5% saccharose; P90CGG.DOXþ, animals administered doxycycline; WO, washout period. Student's t-test, **P < 0.01. 12 þ 3 weeks of doxycycline administration, starting after weaning (P90CGG DOXþ n ¼ 7/9), and in animals treated with an additional 12-week washout period (P90CGGDOXþ.WOn ¼ 7/10). After a 12-week washout period intranuclear inclusions are cleared mostly in the amygdala and hippocampus, but not in the cerebellum (Student's t-test). P90CGG.DOXþ, animals administered doxycycline; P90CGG.DOXþ.WO, doxycycline treated animals submitted to a washout period. BLA, basolateral amygdala, CA1, cornus Ammon 1, CA3, cornus Ammon 3, CeA, central amygdala, DG, dentate gyrus, lb X, lobule X of the cerebellum. Student's t-test, *P < 0.05.
( Fig. 6D-G) . In the open field, P90CGG DOXsþ animals did not show differences in the distance travelled in the arena as compared with P90CGG DOXs-animals ( Fig. 6H ; genotype Â time interaction, F (3, 45) ¼ 3.827, P ¼ 0.0159, which did not survive post hoc comparisons). Although not statistically significant, P90CGG DOXsþ animals showed a trend for a reduction in the percentage of time spent in the centre of the arena as compared with P90CGG DOXs-animals (Fig. 6I , genotype effect, F (1, 15) ¼ 2.990, P ¼ 0.10) that resembles the heightened anxiety observed in the 12-week DOX group.
Following the behavioural testing, animals were allowed for a 12-week DOX washout period and re-tested for anxiety and motor function (P90CGG DOXsþ.WO n ¼ 9, P90CGG DOXs-.WO n ¼ 8). We obtained footprint patterns from these mice and we observed that P90CGG DOXsþ.WO animals now showed a statistically significant reduction in stride length ( Fig. 7A ; t ¼ 2.493, P ¼ 0.025) as compared with P90CGG DOXs-.WO controls. No differences between groups were observed in anxiety levels when animals were tested in the open field, as P90CGG DOXsþ.WO and P90CGG DOXs-.WO animals showed a similar percentage of time spent in the centre of the arena across the 20 min testing session (data not shown). Animals were also tested in a second anxiety paradigm, the light/dark test and also here no differences were detected between genotypes in the percentage of activity in the lit compartment (P90CGG DOXs-.WO, 12.35 6 2.19; P90CGG DOXsþ.WO, 14.88 6 3.27; P > 0.5).
Finally, we quantified the number of intranuclear inclusions in cerebellum lobule X in the behaviourally characterized P90CGG animals after transgene induction (P90CGG DOXsþ n ¼ 4) and additional washout (P90CGG DOXsþ.WO n ¼ 7), but found no differences in the inclusion load (35.5 versus 36.3%, respectively; t ¼ 0.0925, P ¼ 0.93) between groups ( Fig. 7C-E) .
Discussion
In this study, we report that induction of expression of a 90CGG repeat transgene outside of the FMR1 gene context is sufficient for the manifestation of FXTAS-like behavioural deficits in mice. We show heightened anxiety and motor dysfunction, and in particular are able to model for the first time ataxia in a CGG were given an 8-week period of doxycycline administration, starting after weaning, and tested in tests that reflect motor and anxiety performance (P90CGG DOXs-n ¼ 14, P90CGGDOXsþ n ¼ 15). In the rotarod, no differences in motor performance were found between P90CGGDOXsþ and P90CGGDOXs-control animals in the latency to fall off the rod at (A) the training sessions (repeated measures two-way ANOVA) or when testing for (B) motor learning or (C) motor coordination (Student's t-test). Footprints were obtained for all animals and used to analyse the gait pattern by measuring (D) forepaws width, (E) hindpaws width, (F) stride length and (G) uniformity of step alternation. No differences were observed between P90CGG DOXs treatment groups for any of the gait parameters analysed (Student's t-test). In the open field, no differences were observed in (H) the total distance travelled or (I) the percentage of time spent in the centre of the arena (repeated measures two-way ANOVA). Shutdown 90CGG transgene at 8 weeks is sufficient to rescue motor and anxiety levels at this time point. P90CGG.DOXs-, animals administered 5% saccharose; P90CGG.DOXsþ, animals administered doxycycline for 8 weeks. Repeated measures two-way ANOVA, genotype effect, # P < 0.05; time effect, premutation mouse model of FXTAS. Behavioural features are paralleled by the formation of intranuclear inclusions in the cerebellum lobule X, amygdala (CeA and BLA) and hippocampus sub-regions (DG and CA3). Importantly, we demonstrate a spontaneous rescue of anxiety-like behaviour but not of motor impairments after cessation of the 90CGG transgene induction. The P90CGG model constitutes a valuable tool to study FXTAS pathogenesis and to test the effectiveness of new therapeutic strategies against the debilitating FXTAS symptoms.
Main clinical manifestations of FMR1 premutation mimicked in the P90CGG mouse model
Different mouse models of the Fmr1 premutation exist that shed light onto the neurobiology of this recently discovered disorder, but none of the existing models has been so far described to mimic ataxia as one of the principal features of FXTAS patients (reviewed in (23)). Gait ataxia in FXTAS patients is associated with neuropathology in the cerebellum including Purkinje cell loss, dystrophic axons, gliosis and spongy change in the cerebellar white matter (9, 10) . Classically, the cerebellum plays a role in the coordination of movement (30); however, recently a role in executive cognitive functions has been described by regulating motor learning and cognition (31) . In the inducible P90CGG mouse model used in our study, the cerebellum is the most severely affected brain region and shows the highest percentage of FMRpolyG/ubiquitin-positive intranuclear inclusions within the brain. Accordingly, we observed deficits in rotarod performance and altered footprint pattern, both of which rely on a proper function of the cerebellum, validating the inducible P90CGG as an excellent model to study CGG premutation-related ataxia.
Besides the motor component, neuropsychiatric phenotypes have also been reported in both children and adult carriers of the FMR1 premutation with and without FXTAS (reviewed in (32)). These neuropsychiatric phenotypes include neurodevelopmental disorders such as autism spectrum disorder, ADHD and seizures, anxiety and mood disorders and learning disabilities. In fact, the percentage of FMR1 premutation carriers with a clinical diagnosis of any anxiety disorder is of 70.6% as opposed to 22.6% observed in a control group (29) . In a different study, 93% of the proband premutation carriers were found to have symptoms of ADHD, a number that is reduced to 38% in the non-proband premutation carriers group, but still high compared with non-premutation carriers (33) . Interestingly, inducible P90CGG mice in our experiments showed both heightened anxiety and hyperactivity in the home-cage compared with controls and thus allowed us to begin to address underlying neuropathological processes by studying inclusion load in corresponding brain regions, as we discuss below. Many other phenotypes are anecdotally reported to be associated with the FMR1 premutation in humans (depression, phobias, autism) that may now be similarly explored using this inducible P90CGG mouse model.
Brain region-specific rescue of behavioural and pathological FXTAS features in the P90CGG mouse model Stopping transgene expression after induction was sufficient to reverse signs of heightened anxiety in P90CGG animals, but not their motor impairments. These behavioural observations are paralleled by a significant reduction in the number of intranuclear inclusions in the BLA and hippocampus DG, which was not observed in the cerebellum lobule X, where around 35% of cells still present with intranuclear inclusions after washout. We confirmed the previous neuropathology findings on lobule X of the cerebellum in that induction of expression of premutated 90CGG RNA resulted in the profound formation of intranuclear inclusions that were not reversible when mice were taken off DOX after an initial period of 12 weeks or longer (25) . Moreover, our data add to the previously literature that the initial inclusion load is brain region-specific. Importantly, our recovery experiments showed that if premutated CGG mRNA expression is halted, the brain preserved its endogenous ability to clear intranuclear inclusions in certain brain regions and associated behavioural features were improved. This is a region-specific effect that may be determined by the initial inclusion load (threshold effect) or by the qualitative composition of the inclusions. Several proteins bind preferentially to expansions of the CGG repeat in the premutation range and are sequestered in the intranuclear inclusions. Two such proteins are DROSHA and its partner DiGeorge syndrome critical region 8 (DGCR8), both of which are implicated in microRNA processing and decreased levels of mature microRNAs in brain samples from FXTAS patients (18) . Sequestration of Pur a, a CGG repeat-binding protein with a role in dendritic RNA transport, may also contribute to FXTAS pathogenesis (16) . In addition, splicing alterations might also be present in FXTAS as Src-associated substrate during mitosis of 68 kDa protein (Sam68), a RNA-binding protein involved in alternative splicing, is detected in intranuclear inclusions of FXTAS patients and in a CGG repeat cellular model (19) . It will be interesting to study and compare the composition of intranuclear inclusions in different brain regions and to explore whether different local mechanisms are involved in the pathogenesis, and responsible for the wide clinical spectrum associated with the FMR1 premutation.
Pathogenic mechanisms of CGG premutation
Intranuclear inclusions are a neuropathological hallmark present in both neurons and astrocytes across the brain of premutation carriers with FXTAS (9, 34) . Likewise, ubiquitin-positive intranuclear inclusions are observed in the inducible P90CGG mouse model and also in the brain of different premutation knock in (KI) models (21, 22, 25) . Moreover, CGG premutation inclusions in FXTAS patients and in premutation mouse models stain positive for polyglycine and polyalanine peptides (25, 34) that result from a RAN translation mechanism (13) . Both RAN translation and RNA-mediated toxicity may contribute to disease process additively or synergistically. Recently, a study using mouse models with and without FMRpolyG expression suggested a direct contribution of FMRpolyG to toxicity (35) . Colocalization of FMRpolypeptides with ubiquitin-positive inclusions was only observed in the inducible P90CGG and in the Dutch KI mouse models, but not in the NIH mouse that exhibits only a mild behavioural phenotype (13, 25) . The differing behavioural and pathological data between these mouse models (reviewed in (36)) could be explained by differences in the ability to generate the toxic FMRpolypeptides.
In our P90CGG model, it cannot yet be discriminated whether the toxic transgene can affect both behaviour and inclusions independently of each other or behavioural deficits are a result of inclusion formation. Nevertheless, our data suggests a link between the presence of inclusions and the behavioural outcome, since the recovery of normal anxiety levels were accompanied by a reduction of inclusions in the critical brain regions, amygdala and hippocampus. However, inclusion washout did not occur in the cerebellum lobule X and correspondingly motor impairments did not recover. Moreover, after shorted induction of the 90CGG transgene (8 weeks DOX), P90CGG DOXþ animals showed a high intranuclear inclusion load in cerebellum lobule X, but no signs of motor impairments, which only began to develop after the washout period. This suggests that other factors in addition to inclusion formation, such as the specific capacity/homeostasis state of cells to deal with a genetic insult, modulate the deterioration of behavioural functions. These may involve deregulation of protein degradation via the ubiquitin-proteasome system or autophagy, which are involved in many neurodegenerative disorders including Parkinson's disease, Alzheimer's disease and spinocerebellar ataxias. Rapamycin did not ameliorate the neurodegenerative phenotypes of FXTAS in a Drosophila model (37) , suggesting that autophagy may not play a major role in FXTAS pathology. In contrast, impairments in the ubiquitin-proteasome system are prominent in FXTAS models (14, 38) .
Together, we show that inducible expression of a premutation 90CGG repeat transgene in post weaning mice leads to motor dysfunction and heightened anxiety levels. Shutdown of transgene expression allows for selective recovery of anxietylike behaviour and a shortened period of transgene induction can delay, but not preclude the development of motor impairments. These data suggest that the nervous system maintains its capacity for inclusion clearance under CGG expression and that targeting repeat expansions can provide a therapeutic approach for some aspects of the disorder even after the onset of overt symptoms.
Materials and Methods

Animals
Inducible transgenic animals were obtained by crossing single transgenic mutants carrying either a TRE-90CGG repeat tract or a TRE-11CGG repeat tract with the transgenic driver line prion protein-reverse tetracycline transactivator (PrP-rtTA), as described previously (24, 25) . Bigenic mice are accordingly called P90CGG and P11CGG throughout the text. At 4 weeks of age animals were weaned and further on group housed in standard laboratory cages filled with sawdust, paper towel and card rolls. Animals were kept in an inverted 12 h light/12 h dark cycle with controlled temperature and humidity conditions and water and food ad libitum. Genotyping was performed with DNA extracted from tail biopsies according to the published protocol (25) .
All animal experimental procedures were approved under local ethics committee (CEEA #42502-2-1219) and met the guidelines of the local and European regulations (European Union directive no. 2010/63/EU).
Doxycycline (DOX) administration
Previously it was shown that bigenic P90CGG mice administered with DOX for a period of 8, 12 or 16 weeks, starting at after weaning, resulted in the formation of intranuclear inclusions in different brain regions (25) . Here, we used the same mouse model and time windows of transgene activation and aim to assess clinical hallmarks of FXTAS. At 4 weeks of age, transgene expression was activated in P90CGG and P11CGG animals by DOX administration (4 mg/kg) in a 5% saccharose solution in their drinking water for a period of 8 or 12 (61) weeks (P90CGG DOXsþ , P90CGG DOXþ and P11CGG DOXþ groups). Control animals received a 5% saccharose solution as drinking water (P90CGG DOXs-, P90CGG DOX-and P11CGG DOX-groups). The initial behavioural battery was performed with mice on DOX, which lasted 1 week for the 8-week group (DOX short (s)þ/-) and 3 weeks for the 12-week group (DOX þ/-). At weaning animals were randomly allocated to one of the two treatment groups (DOXþ versus DOX-) and animals from the same litter were always represented in both treatment groups to avoid a litter effect. The transgene washout period started after the initial behavioural battery and plain drinking water was provided for a period of 12 weeks, when the second behavioural testing was performed that lasted 1 week.
Behavioural tests
Mice were submitted to a battery of behavioural tests that assess motor and emotional domains. Tests were performed in the following order: rotarod, open field, footprint pattern, fear conditioning, light-dark test and home cage activity. Behavioural data were collected online using appropriated software and therefore independent of the investigator subjectivity. Footprint measures were analyzed a posteriori with the investigator blind for the treatment condition.
Rotarod. Mice were trained and tested in a rotating rod to evaluate their motor learning and motor coordination (UGO BASILE, Varese, Italy). The protocol consisted of three days of training at a constant speed (15 rpm) for a maximum of 60 seconds (s) in four trials. At the fourth day, animals were tested for each of five different speeds (4, 15, 24, 31 and 36 rpm) for a maximum of 60 s in two trials (motor learning protocol). Animals were allowed to rest for 1 h, after which they were tested in a 5 min accelerated ramp from 4 to 40 rpm, in four trials (motor coordination protocol). The latency to fall off the rod was registered.
Open field. Animals were allowed to explore a squared arena (50 cm Â 50 cm Â 50 cm) in a 20-min session, under red light (1 Lux). The total distance travelled was used a measure of activity and the distance travelled and time spent in a predefined centre area (25 cm Â 25 cm) versus the rest of the arena was used to assess anxiety. Movement of mice was tracked using an automated tracking system (ANY-maze TM Video Tracking System, Stoelting Co., USA). Footprint pattern. Fore-and hindpaws of mice were painted using non-toxic ink in different colours (blue and pink, respectively), after which mice were forced to walk on top of a white sheet of paper placed under a methacrylate tunnel. Gait was analysed by taking the following footprint measurements: foreand hindpaws width, stride length and uniformity of step alternation (see Fig. 1D and (39) .
Home-cage activity. To monitor spontaneous circadian activity, animals were single caged in home cages with special covers equipped with infrared movement sensors (Home Cage Activity System, Coulbourn Instruments, Allentown, PA, USA), connected to a PC. Animal movements were registered for three consecutive days using the manufacturer's build-in software. Raw values of 15 s of activity were collected at 0.01 Hz and used to detect activity periods in 5 min bins. The percentage of active periods per hour was calculated and is presented.
Fear conditioning. Mice were tested in the fear conditioning apparatus (TSE, Bad Hamburg, Germany) and freezing behaviour was automatically recorded using commercial software. Freezing response is a reliable measure of conditioned fear in rodents and is defined as lack of movement other than breeding for at least 1 s. The protocol consisted of one habituation session composed of 2 min exploration, three tones presentation (CS-: 2.5 kHz, 10 s, inter-stimulus interval (ISI) 20 s) and a final 2 min exploration phase. Twenty-four hours later, animals were trained in the same chamber in a session composed of 2 min exploration, followed by three tone-shock presentations (CSþ: 10 kHz, 9 s; US: 0.4 mA, 1 s; ISI, 20 s) and a final 2 min exploration. On the following day mice were tested in the same box for contextual fear memory in a 3 min session. On the last day, mice were placed in a new box (similar to the home-cage and with clean bedding material) and tested for cued fear memory in a session composed of 2 min exploration, followed by three CS-presentations plus three CSþ presentations (without US presentation) and a final 2 min exploration period.
Light-dark test. Animals were placed in the dark compartment of a standard light/dark box and their behaviour was recorded for 5 min using a photo beam system (TSE). The percentage of activity (movement at a velocity of more than 3 cm/s) in the lit compartment was used as a measure of anxiety.
Immunohistochemistry for ubiquitin and FMRpolyG peptide
Animals were sacrificed by decapitation, brains were removed and kept in 4% paraformaldehyde (PFA) overnight at 4 C and then passed to 2% PFA. Brains were included in paraffin blocks according to standard protocols. Microtome sections (6 mm) were cut and deparaffinized followed by antigen retrieval using microwave treatment in sodium citrate 0.01 M (pH 6). In order to better visualize inclusions an extra antigen retrieval step was added, using proteinase K. Endogenous peroxidase activity was blocked and immunostaining was performed overnight at 4 C using rabbit anti-ubiquitin (Dako Z0458; 1:250) or mouse antiFMRpolyG (8FM(9); 1:10) antibodies. Antigen-antibody complexes were visualized by incubation with DAB substrate (Dako K3468) after incubation with Brightvision poly-HRP-linker (Immunologic; DPVO-HRP55). Slides were counterstained with haematoxylin and mounted with Entellan TM . Inclusions were quantified by counting nuclei and by counting the number of ubiquitin-positive inclusions at a 100Â magnification. The percentage of nuclei with intranuclear inclusions was calculated and is presented. Researchers were blinded for genotype and treatment.
Statistical analysis
For simple group comparisons Student's t-test or MannWhitney U test were used. Two-way ANOVA was used when two factors were compared. Repeated measures two-way ANOVA was used when repeated measures were available for one of the factors. Statistical analysis was performed using SPSS package (version 22). A value of P < 0.05 was considered statistically significant throughout the study.
